Voting Under Way for 2012 NTRA Moment of Year
The Blood-Horse Staff
December 15, 2012
This year’s ballot includes two horse health-related events.
This year’s ballot includes two horse health-related events.
Many leaders believe sweeping medication reform could become a reality in early 2013.
The changes are designed to prevent mistakes in Salix administration prior to races.
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
Economists are forecasting an upturn in equine receipts in 2013 after the industry saw steady sales in 2012.
Dr. Lisa Fortier recaps studies on upper respiratory tract health, colic, lameness, and racehorse health.
The Thoroughbred Charities of America appointed Eric Hamelback and Michael McMahon to its board of directors.
A panel discussed dealing with drug violators in horse racing and reported progress.
The storm had a significant effect on wagering during the Nov. 2-3 Breeders’ Cup races, held in California.
Fans can vote for the seven nominees until Dec. 23.
Tim Morris, DVM, PhD, will leave the organization as part of the ongoing restructure of BHA services.
The winner of the Darley Prix Jean Romanet was disqualified after testing positive for an anti-inflammatory.
A Nov. 26 positive EHV-1 test extends the Hawthorne quarantine until at least Dec. 24.
Regulators could ban horses from racing or breezing for at least 10 days after shock wave therapy treatments.
The outbreak appears to be contained, but shipping restrictions have made it challenging to fill races.
The event supports lower-income Kentucky Thoroughbred horsemen and their families.
Stay on top of the most recent Horse Health news with
